Security key
09074H203
BIOTRICITY INC. - Common Stock, par value $0.001 per share (BTCY)
CUSIP: 09074H203
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 48,263
- Total 13F value
- $25,579
- Share change
- +48,263
- SEC-reported price per share
- $0.53
- Number of holders
- 1
- Value change
- +$25,579
- Number of buys
- 1
- Shares outstanding
- 31,282,697
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
1
Top holders
1
BTCY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q4 2024
BIOTRICITY INC. SEC filings
BIOTRICITY INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09074H203
Recent filing periods:
Ownership snapshot
Top reported holders of BTCY - BIOTRICITY INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Norman M. Betts
Disclosed value leader
Norman M. Betts
Comparable rows
0/4
Latest evidence
12 Mar 2023
3/4/5
Highest disclosed value: $1,145,574
4 rows are not safely comparable across share classes.
Quick read
Norman M. Betts has the largest disclosed position value at $1.15M.
0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Norman M. Betts's linked filing trail.
Disclosed position value
Top 1
Norman M. Betts
$1.15M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-4 of 4 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Norman M. Betts |
3/4/5
Director
|
—
class O/S missing
|
$1,145,574
375,598 shares
|
— | 29 Nov 2021 |
| Waqaas Al-Siddiq |
3/4/5
President, CEO and Chairman, Director
|
—
class O/S missing
|
—
4,899,984 shares
|
— | 12 Mar 2023 |
| John Ayanoglou |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
—
1,328,488 shares
|
— | 26 Oct 2017 |
| David A. Rosa |
3/4/5
Director
|
—
class O/S missing
|
—
474,683 shares
|
— | 12 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
48,263
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q4 2024 Across Filers
Q4 2024 holders
0
Q3 2025 holders
1
Holder diff
1
| Investor | Q4 2024 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend